AMAG Pharmaceuticals, Inc.



$14.40Share Price
$508 MMarket Cap
11.3%EBIT / EV
8.0%FCF / EV
5.9%Cash ROIC
105.8%3yr Avg Revenue Growth
1.59Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 11.3% ranks as Very High.
check mark The Free Cash Flow / Enterprise Value of 8.0% ranks as Very High.
x mark The Return on Invested Capital Value of 8.4% ranks as Below Average.
x mark The Cash Return on Capital Value of 5.9% ranks as Below Average.
check mark The 3 Year Average Revenue Growth Value of 105.8% ranks as Very High.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 1.59.

Company Description

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. It focuses on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron deficiency anemia or IDA. The company engages in manufacture, development and commercialization of products derived from its proprietary technology for use in treating human diseases. The company's products includes Intrarosa, Makena, CBR, Feraheme, and MuGard. AMAG Pharmaceuticals was founded on 9th, November 1981 and is headquartered in Waltham, MA.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!